Skip to content
The Policy VaultThe Policy Vault

Noxafil (posaconazole delayed-release tablets [generic], oral suspension [generic], PowderMix for delayed-release oral suspension - Merck)Cigna

Patient is Currently Receiving Posaconazole

Initial criteria

  • Patient is currently on posaconazole and requires additional time to complete course of therapy

Approval duration

3 months